Evidence map›Paper›PMID 37204680›Full record

ArticleDrug delivery and translational research2023

Medium-chain triglyceride-stabilized docetaxel-loaded HSA nanoparticles effectively inhibited metastatic non-small cell lung cancer.

Yunlong Cheng, Xiaoying Pang, Jing Wu, Lingling Zhou, Jinxu Cao, Liuchang Wang, Kang Qian, Peng Yang, Minjun Xu, Dongyu Sheng and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Yunlong Cheng *Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Xiaoying Pang *Department of Pharmacy, the Obstetrics and Gynecology Hospital, Fudan University, 200011, Shanghai, China.
Jing WuKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Lingling ZhouKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Jinxu CaoKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Liuchang WangKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Kang QianKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Peng YangKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Minjun XuKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Dongyu ShengKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Ran MengKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Pengzhen WangKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Qian GuoKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Shuting XuKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China.
Yan WeiInstitute of Translational Medicine, Shanghai University, Shanghai, 200444, China. ywei@shu.edu.cn.
Qizhi ZhangKey Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, China. qzzhang@fudan.edu.cn.ORCID 0000-0002-8544-609X
Fudan University · CNObstetrics and Gynecology Hospital of Fudan University · CNShanghai University · CN

Funding

National Natural Science Foundation of China 81703010National Natural Science Foundation of China 81872428Shanghai Municipal Natural Science Foundation 19ZR1406200
6 · The paper itself

Abstract

Metastatic non-small cell lung cancer (NSCLC) is refractory with a very poor prognosis. Docetaxel (DTX) injection (Taxotere

Indexed as

Antineoplastic AgentsCarcinoma, Non-Small-Cell LungDocetaxelLung NeoplasmsNanoparticlesSerum Albumin, HumanTriglyceridesAnimalsCell Line, TumorCell MovementCell ProliferationDrug CarriersDrug LiberationHumansMaleMiceAntineoplastic AgentsDocetaxelDrug CarriersSerum Albumin, HumanTriglyceridesDocetaxelHuman serum albumin nanoparticlesMedium-chain triglycerideMetastatic non-small cell lung cancer

Identifiers

PMID37204680
OpenAlexW4377093318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.